Cite
Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial
MLA
Kjetil Weyde, et al. “Tobramycin Once versus Three Times Daily, given with Penicillin G, to Febrile Neutropenic Cancer Patients in Norway: A Prospective, Randomized, Multicentre Trial.” The Journal of Antimicrobial Chemotherapy, vol. 59, no. 4, Mar. 2007. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....955c2fca4470774957d28d3f8a7123e4&authtype=sso&custid=ns315887.
APA
Kjetil Weyde, Arne E. Høiby, Dag Torfoss, B. Sandstad, Anne B. Jacobsen, Harald Holte, Stein Kvaløy, Kjell Grøttum, Jon Magnus Tangen, Kåre Bø, Grete F. Lauritzsen, Peter Meyer, & Harald Olsen. (2007). Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial. The Journal of Antimicrobial Chemotherapy, 59(4).
Chicago
Kjetil Weyde, Arne E. Høiby, Dag Torfoss, B. Sandstad, Anne B. Jacobsen, Harald Holte, Stein Kvaløy, et al. 2007. “Tobramycin Once versus Three Times Daily, given with Penicillin G, to Febrile Neutropenic Cancer Patients in Norway: A Prospective, Randomized, Multicentre Trial.” The Journal of Antimicrobial Chemotherapy 59 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....955c2fca4470774957d28d3f8a7123e4&authtype=sso&custid=ns315887.